SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-005904
Filing Date
2023-02-24
Accepted
2023-02-23 17:38:38
Documents
5
Period of Report
2023-02-23

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 295260
2 formdef14a_001.jpg GRAPHIC 4136
3 formdef14a_002.jpg GRAPHIC 815
4 proxy_001.jpg GRAPHIC 774568
5 proxy_002.jpg GRAPHIC 472076
  Complete submission text file 0001493152-23-005904.txt   2020126
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38306 | Film No.: 23661249
SIC: 2834 Pharmaceutical Preparations